Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Retatrutide for Sale > Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5
Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5 buy - large image1
Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5 buy - image1
Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5 buy - image2
Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5 buy - image3
Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5 buy - image4
Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5 buy - image5
Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5 buy - image6

Warehouse Supply Hot Selling Factory 99% Glucagon Powder CAS 16941-32-5

7504 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

xian

Brand:

Fulecare

Packaging:

Double plastic bags plus aluminum foil bag

Sample Available:

Yes

Price valid (until):

2026-07-18

Company Type:
Trader
Location:
China
Payment Terms:
L/C,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
335 days
Qualification:
Main Products:

Slu-pp-332,BAM 15

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Shop Factory Supply Bam 15 Powder Bam 15 210302-17-3-Detailed Image 1

    Produsts Name Glucagon
    CAS No 2381089-83-2
    Purity >99%
    Appearance White  powder
    storage keep in a cool,dark location in a tightly sealed container or cylinder.
    Shelf Life  24 Months


    Glucagon is a polypeptide hormone produced by pancreatic alpha cells that plays a crucial role in blood glucose regulation. By activating specific receptors on hepatocyte membranes, it promotes hepatic glycogenolysis and gluconeogenesis, rapidly elevating blood glucose levels. This hormone is primarily used to treat severe hypoglycemia, especially in emergency situations caused by overdose, serving as a rescue medication to quickly restore blood glucose concentrations. It is also employed during gastrointestinal endoscopy to temporarily inhibit gastrointestinal motility.

    Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 2 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 3 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 4

    Xi’an Fulecare biotech has high-technique enterprises with 10 years history,dedicate to separation, purification of the natural active ingredients production and sales.

    We also produce international frontier dietary supplements such as granulated powder,solid drinks,tea sachets, capsules and tablets etc.

    We have high grade clean workshop,800 square meters of inspection center equipped with more than 10 sets of HPLC,GC,IR,MASS instruments,these provides a full range of quality assurance to our products

    The company has a perfect quality assurance system.We implement strict quality control standards and have passed the certification for the ISO9001 Quality Management System. The Quality Management Department is equipped with many sets of high performance liquid chromatography (HPLC)instruments, ultraviolet spectrophotometers (UV), several spectropolarimeters, a gas chromatograph (GC), melting point apparatus, and other advanced testing and experimental equipment. We make a detailed division of labor for technology research, and for quality assurance and quality control, so that we can conduct effective and comprehensive quality control in the production process. This also allows us to make comprehensive detection analysis of final products, thus ensuring products quality.

    Our Services


    Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 5 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 6

    Packaging & Shipping


    Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 7

    DHL Around 3-5 working days
    Fedex Around 4-6 working days
    UPS Around 4-6 working days
    By Air Around 5-7 working days
    By Sea Around 15-30 working days


    Package

    Powder:1kg per bag,25kg per Carton or Drum

    PE bag, glass bottle, or PTFE bottle for inner packing, and aluminum foil bag for outer packing.

    Liquid: glass bottle or PTFE bottle for inner packing, and aluminum foil bag for outer packing.

    Bulk order: Fiber drum or steel drum.

    Payment options T/T,Paypal,Visa,L/C or according to your needs.

    Transportation
     
    UPS,TNT,EMS,Fedex,and so on.According to your location, safe customs clearance, generally delivered to your door within 3-7 days in Europe and the United States.

    Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 8 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 9 Shop Pharmaceutical CAS 1792180-81-4 Ritlecitinib Powder Ritlecitinib-Detailed Image 10

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Slu-pp-332,BAM 15

    Location:

    No. 11608, 16th Floor, Unit 1, Building 1, West of Zhangba Liu Road, South Third Ring Road, High tech Zone, Xi'an City, Shaanxi Province

    Payment Terms:

    L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    335 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    11-50

    Year of Establishment:

    2025

  • Inquiry History
    7504 Inquiries
    Country Product Purchase Quantity Date Posted
    Spain

    Retatrutide

    100 G Oct 30, 2026
    Brazil

    Retatrutide

    10  Oct 29, 2026
    Australia

    Retaturtide

    100 MG Oct 29, 2026
    United States

    Retatrutide 30mg and 50mg

    20 PCS Oct 29, 2026
    Belgium

    Retatrutide

    1 MG Oct 29, 2026
    Romania

    Retatrutide

    10 G Oct 29, 2026
    United States

    Retatrutide

    2 MT Oct 29, 2026
    United States

    Retatrutide

    1 MT Oct 29, 2026
    United Kingdom

    Retatrutide

    1 PCS Oct 28, 2026
    United States

    Retatrutide

    30 MT Oct 28, 2026
    United Kingdom

    Retatrutide

    10 MT Oct 28, 2026
    Malaysia

    Retatrutide

    20 MG Oct 28, 2026
    United States

    retatrutide

    30 MG Oct 28, 2026
    Czech

    Retatrutide

    10 MG Oct 28, 2026
    Austria

    retatrutide

    30 MG Oct 28, 2026
    United States

    Retatrutide

    100 KG Oct 28, 2026
    Malta

    Retatrutide

    10 MT Oct 28, 2026
    United States

    Retatrutide

    600 MG Oct 28, 2026
    United States

    Retatrutide

    500 G Oct 28, 2026
    United States

    Retatrutide

    60 G Oct 28, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.